10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time.
加州普萊森頓,2025年1月2日 / PRNewswire / -- 10x Genomics公司(納斯達克:TXG),一家單細胞和空間生物學的領導者,今天宣佈其管理團隊成員將在1月13日星期一太平洋時間上午7:30參加第43屆摩根大通醫療保健大會進行演講。
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: . The webcast will be archived and available for replay for at least 30 days after the event.
感興趣的各方可以通過公司網站的"投資者"部分訪問直播網絡研討會。該網絡研討會將被存檔,並在活動後至少30天內可供重播。
About 10x Genomics
10x Genomics是一家生命科學技術公司,致力於打造能夠加速生物學掌握和促進人體健康的產品。我們的綜合解決方案包括單細胞和空間生物學的儀器、消耗品和軟體,幫助學術和轉化研究人員以及生物製藥公司以與生物學複雜性相匹配的分辨率和尺度理解生物系統。我們的產品在腫瘤學、免疫學、神經科學等方面取得了突破性進展,推動了深入理解健康和疾病的強大發現。如欲了解更多信息,敬請訪問10xgenomics.com。
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).
10x Genomics是一家生命科學科技公司,致力於開發產品以加速對生物學的掌握並促進人類健康。我們的綜合解決方案包括單細胞和空間生物學的儀器、耗材和軟體,幫助學術和轉化研究人員以及生物製藥公司以匹配生物學複雜性的分辨率和範圍理解生物系統。我們的產品支持在腫瘤學、免疫學、神經科學等領域的突破性進展,推動強大的發現,改變着世界對健康和疾病的理解。要了解更多信息,請訪問10xgenomics.com或在LinkedIn或X(Twitter)上與我們聯繫。
Disclosure Information
披露信息
10x Genomics uses filings with the Securities and Exchange Commission, our website (), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
10x Genomics利用向證券交易委員會(SEC)提交的文件、我們的網站()、新聞稿、公開電話會議、公共網絡研討會和我們的社交媒體賬戶作爲披露重要非公開信息的手段,並遵守《FD法規》下的披露義務。
Contacts
聯繫人
Investors: [email protected]
投資者: [email protected]
Media: [email protected]
媒體: [email protected]
SOURCE 10x Genomics, Inc.
來源 10x Genomics, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想讓貴公司的資訊在PRNEWSWIRE.COM上特色展示嗎?
譯文內容由第三人軟體翻譯。